nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabrafenib—Azotaemia—Metformin—metabolic syndrome X	0.015	0.0873	CcSEcCtD
Dabrafenib—LIMK1—adipose tissue—metabolic syndrome X	0.0134	0.13	CbGeAlD
Dabrafenib—Rigors—Metformin—metabolic syndrome X	0.00977	0.057	CcSEcCtD
Dabrafenib—BRAF—adipose tissue—metabolic syndrome X	0.00831	0.0803	CbGeAlD
Dabrafenib—SIK1—kidney—metabolic syndrome X	0.00772	0.0746	CbGeAlD
Dabrafenib—SIK1—adipose tissue—metabolic syndrome X	0.00695	0.0672	CbGeAlD
Dabrafenib—RAF1—cardiovascular system—metabolic syndrome X	0.00628	0.0607	CbGeAlD
Dabrafenib—RAF1—kidney—metabolic syndrome X	0.00614	0.0594	CbGeAlD
Dabrafenib—BRAF—liver—metabolic syndrome X	0.00583	0.0563	CbGeAlD
Dabrafenib—Pain in extremity—Metformin—metabolic syndrome X	0.00579	0.0338	CcSEcCtD
Dabrafenib—RAF1—adipose tissue—metabolic syndrome X	0.00553	0.0535	CbGeAlD
Dabrafenib—Dehydration—Metformin—metabolic syndrome X	0.00539	0.0314	CcSEcCtD
Dabrafenib—Abdominal pain upper—Metformin—metabolic syndrome X	0.00529	0.0308	CcSEcCtD
Dabrafenib—Nasopharyngitis—Metformin—metabolic syndrome X	0.00518	0.0302	CcSEcCtD
Dabrafenib—SLCO1B3—liver—metabolic syndrome X	0.00502	0.0485	CbGeAlD
Dabrafenib—Pancreatitis—Metformin—metabolic syndrome X	0.00491	0.0286	CcSEcCtD
Dabrafenib—SIK1—liver—metabolic syndrome X	0.00488	0.0471	CbGeAlD
Dabrafenib—Abdominal discomfort—Metformin—metabolic syndrome X	0.0048	0.028	CcSEcCtD
Dabrafenib—Neutropenia—Metformin—metabolic syndrome X	0.00468	0.0273	CcSEcCtD
Dabrafenib—SLCO1B1—kidney—metabolic syndrome X	0.00459	0.0444	CbGeAlD
Dabrafenib—Infestation—Metformin—metabolic syndrome X	0.00446	0.026	CcSEcCtD
Dabrafenib—Infestation NOS—Metformin—metabolic syndrome X	0.00446	0.026	CcSEcCtD
Dabrafenib—Oedema peripheral—Metformin—metabolic syndrome X	0.00395	0.023	CcSEcCtD
Dabrafenib—Connective tissue disorder—Metformin—metabolic syndrome X	0.00394	0.023	CcSEcCtD
Dabrafenib—RAF1—liver—metabolic syndrome X	0.00388	0.0375	CbGeAlD
Dabrafenib—Eye disorder—Metformin—metabolic syndrome X	0.00374	0.0218	CcSEcCtD
Dabrafenib—Angiopathy—Metformin—metabolic syndrome X	0.00364	0.0212	CcSEcCtD
Dabrafenib—Immune system disorder—Metformin—metabolic syndrome X	0.00362	0.0211	CcSEcCtD
Dabrafenib—Mediastinal disorder—Metformin—metabolic syndrome X	0.00361	0.0211	CcSEcCtD
Dabrafenib—Chills—Metformin—metabolic syndrome X	0.0036	0.021	CcSEcCtD
Dabrafenib—SLC22A8—kidney—metabolic syndrome X	0.00357	0.0345	CbGeAlD
Dabrafenib—Erythema—Metformin—metabolic syndrome X	0.00349	0.0203	CcSEcCtD
Dabrafenib—Malnutrition—Metformin—metabolic syndrome X	0.00349	0.0203	CcSEcCtD
Dabrafenib—Muscle spasms—Metformin—metabolic syndrome X	0.00335	0.0195	CcSEcCtD
Dabrafenib—Vision blurred—Metformin—metabolic syndrome X	0.00329	0.0192	CcSEcCtD
Dabrafenib—Hypertension—Metformin—metabolic syndrome X	0.00301	0.0176	CcSEcCtD
Dabrafenib—Myalgia—Metformin—metabolic syndrome X	0.00297	0.0173	CcSEcCtD
Dabrafenib—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00295	0.0172	CcSEcCtD
Dabrafenib—SLCO1B1—liver—metabolic syndrome X	0.0029	0.0281	CbGeAlD
Dabrafenib—ABCB1—blood vessel—metabolic syndrome X	0.00287	0.0277	CbGeAlD
Dabrafenib—Oedema—Metformin—metabolic syndrome X	0.00285	0.0166	CcSEcCtD
Dabrafenib—Infection—Metformin—metabolic syndrome X	0.00283	0.0165	CcSEcCtD
Dabrafenib—Nervous system disorder—Metformin—metabolic syndrome X	0.00279	0.0163	CcSEcCtD
Dabrafenib—Thrombocytopenia—Metformin—metabolic syndrome X	0.00279	0.0162	CcSEcCtD
Dabrafenib—Skin disorder—Metformin—metabolic syndrome X	0.00277	0.0161	CcSEcCtD
Dabrafenib—Hyperhidrosis—Metformin—metabolic syndrome X	0.00275	0.016	CcSEcCtD
Dabrafenib—Hypotension—Metformin—metabolic syndrome X	0.00266	0.0155	CcSEcCtD
Dabrafenib—CYP2C8—kidney—metabolic syndrome X	0.00261	0.0253	CbGeAlD
Dabrafenib—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00259	0.0151	CcSEcCtD
Dabrafenib—Decreased appetite—Metformin—metabolic syndrome X	0.00247	0.0144	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.00246	0.0143	CcSEcCtD
Dabrafenib—Fatigue—Metformin—metabolic syndrome X	0.00245	0.0143	CcSEcCtD
Dabrafenib—Constipation—Metformin—metabolic syndrome X	0.00243	0.0142	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00233	0.0136	CcSEcCtD
Dabrafenib—ABCG2—adipose tissue—metabolic syndrome X	0.00229	0.0221	CbGeAlD
Dabrafenib—Abdominal pain—Metformin—metabolic syndrome X	0.00225	0.0131	CcSEcCtD
Dabrafenib—Asthenia—Metformin—metabolic syndrome X	0.00204	0.0119	CcSEcCtD
Dabrafenib—Pruritus—Metformin—metabolic syndrome X	0.00201	0.0117	CcSEcCtD
Dabrafenib—Diarrhoea—Metformin—metabolic syndrome X	0.00195	0.0114	CcSEcCtD
Dabrafenib—Dizziness—Metformin—metabolic syndrome X	0.00188	0.011	CcSEcCtD
Dabrafenib—Vomiting—Metformin—metabolic syndrome X	0.00181	0.0106	CcSEcCtD
Dabrafenib—Rash—Metformin—metabolic syndrome X	0.00179	0.0105	CcSEcCtD
Dabrafenib—Dermatitis—Metformin—metabolic syndrome X	0.00179	0.0105	CcSEcCtD
Dabrafenib—Headache—Metformin—metabolic syndrome X	0.00178	0.0104	CcSEcCtD
Dabrafenib—CYP3A4—kidney—metabolic syndrome X	0.00177	0.0171	CbGeAlD
Dabrafenib—Nausea—Metformin—metabolic syndrome X	0.00169	0.00986	CcSEcCtD
Dabrafenib—CYP2C8—liver—metabolic syndrome X	0.00165	0.016	CbGeAlD
Dabrafenib—ABCG2—liver—metabolic syndrome X	0.00161	0.0155	CbGeAlD
Dabrafenib—ABCB1—cardiovascular system—metabolic syndrome X	0.00128	0.0124	CbGeAlD
Dabrafenib—ABCB1—kidney—metabolic syndrome X	0.00125	0.0121	CbGeAlD
Dabrafenib—ABCB1—adipose tissue—metabolic syndrome X	0.00113	0.0109	CbGeAlD
Dabrafenib—CYP3A4—liver—metabolic syndrome X	0.00112	0.0108	CbGeAlD
Dabrafenib—ABCB1—liver—metabolic syndrome X	0.000792	0.00765	CbGeAlD
Dabrafenib—BRAF—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000137	0.00019	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—HTR2C—metabolic syndrome X	0.000137	0.000189	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CD36—metabolic syndrome X	0.000137	0.000189	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—ALB—metabolic syndrome X	0.000136	0.000188	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—IL6—metabolic syndrome X	0.000136	0.000188	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	0.000136	0.000187	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	0.000136	0.000187	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—AGT—metabolic syndrome X	0.000135	0.000186	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—LPL—metabolic syndrome X	0.000135	0.000186	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—FABP4—metabolic syndrome X	0.000135	0.000186	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ABCA1—metabolic syndrome X	0.000134	0.000185	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—SLC2A4—metabolic syndrome X	0.000134	0.000185	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—AGT—metabolic syndrome X	0.000134	0.000185	CbGpPWpGaD
Dabrafenib—RAF1—Disease—LPL—metabolic syndrome X	0.000133	0.000184	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CYBA—metabolic syndrome X	0.000133	0.000183	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—APOE—metabolic syndrome X	0.000131	0.000181	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—G6PD—metabolic syndrome X	0.000131	0.00018	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—IL6—metabolic syndrome X	0.000131	0.00018	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—GHRL—metabolic syndrome X	0.00013	0.000179	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—GGT1—metabolic syndrome X	0.00013	0.000179	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—GOT1—metabolic syndrome X	0.00013	0.000179	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—APOA1—metabolic syndrome X	0.00013	0.000179	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	0.000129	0.000178	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—HSD11B1—metabolic syndrome X	0.000128	0.000176	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—HDAC3—metabolic syndrome X	0.000128	0.000176	CbGpPWpGaD
Dabrafenib—BRAF—Disease—SERPINE1—metabolic syndrome X	0.000127	0.000175	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—AKT1—metabolic syndrome X	0.000125	0.000173	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—LPA—metabolic syndrome X	0.000125	0.000172	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GCKR—metabolic syndrome X	0.000125	0.000172	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ABCA1—metabolic syndrome X	0.000124	0.000171	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—SLC2A4—metabolic syndrome X	0.000124	0.000171	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CRP—metabolic syndrome X	0.000124	0.000171	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CNR1—metabolic syndrome X	0.000123	0.00017	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—IL6—metabolic syndrome X	0.000123	0.00017	CbGpPWpGaD
Dabrafenib—BRAF—Disease—NOS3—metabolic syndrome X	0.000121	0.000167	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PLA2G6—metabolic syndrome X	0.000121	0.000167	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—AKT1—metabolic syndrome X	0.000121	0.000166	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—GOT1—metabolic syndrome X	0.00012	0.000166	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—GGT1—metabolic syndrome X	0.00012	0.000166	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	0.00012	0.000165	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—APOA5—metabolic syndrome X	0.00012	0.000165	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	0.000118	0.000162	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	0.000118	0.000162	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—TGFB1—metabolic syndrome X	0.000117	0.000161	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—FMO3—metabolic syndrome X	0.000117	0.000161	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	0.000116	0.00016	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—AGT—metabolic syndrome X	0.000115	0.000159	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—TGFB1—metabolic syndrome X	0.000114	0.000158	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PPARG—metabolic syndrome X	0.000114	0.000158	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—G6PD—metabolic syndrome X	0.000114	0.000157	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	0.000114	0.000157	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—APOE—metabolic syndrome X	0.000113	0.000156	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—LEP—metabolic syndrome X	0.000113	0.000156	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	0.000112	0.000155	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—INS—metabolic syndrome X	0.000112	0.000155	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—APOA1—metabolic syndrome X	0.000112	0.000154	CbGpPWpGaD
Dabrafenib—RAF1—Disease—APOE—metabolic syndrome X	0.000112	0.000154	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CCL2—metabolic syndrome X	0.000111	0.000154	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—HDAC3—metabolic syndrome X	0.000111	0.000153	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—TRIB3—metabolic syndrome X	0.000111	0.000153	CbGpPWpGaD
Dabrafenib—BRAF—Disease—PTGS2—metabolic syndrome X	0.000111	0.000153	CbGpPWpGaD
Dabrafenib—RAF1—Disease—APOA1—metabolic syndrome X	0.00011	0.000152	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—APOB—metabolic syndrome X	0.00011	0.000152	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	0.00011	0.000151	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—TNF—metabolic syndrome X	0.000109	0.00015	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GCKR—metabolic syndrome X	0.000109	0.00015	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—LPA—metabolic syndrome X	0.000109	0.00015	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IRS1—metabolic syndrome X	0.000108	0.000149	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PLA2G4A—metabolic syndrome X	0.000107	0.000148	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PLA2G6—metabolic syndrome X	0.000105	0.000145	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—LPL—metabolic syndrome X	0.000105	0.000145	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—APOA5—metabolic syndrome X	0.000104	0.000144	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	0.000104	0.000143	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	0.000104	0.000143	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—ALB—metabolic syndrome X	0.000103	0.000142	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—APOB—metabolic syndrome X	0.000102	0.000141	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—IRS1—metabolic syndrome X	0.000101	0.000139	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—IGF2—metabolic syndrome X	0.000101	0.000139	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—CD36—metabolic syndrome X	9.99e-05	0.000138	CbGpPWpGaD
Dabrafenib—RAF1—Disease—IRS1—metabolic syndrome X	9.97e-05	0.000137	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—NAMPT—metabolic syndrome X	9.97e-05	0.000137	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	9.93e-05	0.000137	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PLA2G4A—metabolic syndrome X	9.92e-05	0.000137	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	9.91e-05	0.000137	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GCK—metabolic syndrome X	9.9e-05	0.000137	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—LIPC—metabolic syndrome X	9.9e-05	0.000137	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—APOC3—metabolic syndrome X	9.84e-05	0.000136	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—NOS3—metabolic syndrome X	9.83e-05	0.000136	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—APOB—metabolic syndrome X	9.78e-05	0.000135	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	9.76e-05	0.000135	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—LPL—metabolic syndrome X	9.74e-05	0.000134	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—TRIB3—metabolic syndrome X	9.68e-05	0.000134	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—INS—metabolic syndrome X	9.66e-05	0.000133	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CETP—metabolic syndrome X	9.55e-05	0.000132	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CCL5—metabolic syndrome X	9.55e-05	0.000132	CbGpPWpGaD
Dabrafenib—RAF1—Disease—INS—metabolic syndrome X	9.55e-05	0.000132	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—PLA2G4A—metabolic syndrome X	9.51e-05	0.000131	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CCL2—metabolic syndrome X	9.51e-05	0.000131	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—IGF1—metabolic syndrome X	9.35e-05	0.000129	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—LPL—metabolic syndrome X	9.34e-05	0.000129	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	9.31e-05	0.000128	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PPARA—metabolic syndrome X	9.29e-05	0.000128	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—CD36—metabolic syndrome X	9.25e-05	0.000128	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—SCARB1—metabolic syndrome X	9.15e-05	0.000126	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—AGT—metabolic syndrome X	9e-05	0.000124	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PTGS2—metabolic syndrome X	8.99e-05	0.000124	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	8.91e-05	0.000123	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—SREBF1—metabolic syndrome X	8.88e-05	0.000123	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—SERPINE1—metabolic syndrome X	8.88e-05	0.000122	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—APOE—metabolic syndrome X	8.82e-05	0.000122	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—IL6—metabolic syndrome X	8.78e-05	0.000121	CbGpPWpGaD
Dabrafenib—RAF1—Disease—SERPINE1—metabolic syndrome X	8.77e-05	0.000121	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—APOA1—metabolic syndrome X	8.71e-05	0.00012	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—NAMPT—metabolic syndrome X	8.68e-05	0.00012	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—HMGCR—metabolic syndrome X	8.64e-05	0.000119	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GOT2—metabolic syndrome X	8.64e-05	0.000119	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GCK—metabolic syndrome X	8.63e-05	0.000119	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—LIPC—metabolic syndrome X	8.63e-05	0.000119	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PPARA—metabolic syndrome X	8.6e-05	0.000119	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—APOC3—metabolic syndrome X	8.57e-05	0.000118	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—NOS3—metabolic syndrome X	8.47e-05	0.000117	CbGpPWpGaD
Dabrafenib—RAF1—Disease—NOS3—metabolic syndrome X	8.37e-05	0.000115	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—AGT—metabolic syndrome X	8.33e-05	0.000115	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CETP—metabolic syndrome X	8.32e-05	0.000115	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—FABP4—metabolic syndrome X	8.3e-05	0.000114	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	8.17e-05	0.000113	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—APOE—metabolic syndrome X	8.16e-05	0.000113	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—AKT1—metabolic syndrome X	8.1e-05	0.000112	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—APOA1—metabolic syndrome X	8.07e-05	0.000111	CbGpPWpGaD
Dabrafenib—BRAF—Disease—TGFB1—metabolic syndrome X	8e-05	0.00011	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—AGT—metabolic syndrome X	7.99e-05	0.00011	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—SCARB1—metabolic syndrome X	7.97e-05	0.00011	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—AKT1—metabolic syndrome X	7.95e-05	0.00011	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	7.87e-05	0.000109	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—LEP—metabolic syndrome X	7.83e-05	0.000108	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—APOE—metabolic syndrome X	7.83e-05	0.000108	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	7.79e-05	0.000107	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—IL6—metabolic syndrome X	7.76e-05	0.000107	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—SREBF1—metabolic syndrome X	7.74e-05	0.000107	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—APOA1—metabolic syndrome X	7.74e-05	0.000107	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ABCA1—metabolic syndrome X	7.7e-05	0.000106	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—SLC2A4—metabolic syndrome X	7.7e-05	0.000106	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PPARG—metabolic syndrome X	7.68e-05	0.000106	CbGpPWpGaD
Dabrafenib—RAF1—Disease—PTGS2—metabolic syndrome X	7.66e-05	0.000106	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—INS—metabolic syndrome X	7.53e-05	0.000104	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—HMGCR—metabolic syndrome X	7.53e-05	0.000104	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GOT2—metabolic syndrome X	7.53e-05	0.000104	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GOT1—metabolic syndrome X	7.46e-05	0.000103	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GGT1—metabolic syndrome X	7.46e-05	0.000103	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	7.38e-05	0.000102	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—AKT1—metabolic syndrome X	7.16e-05	9.87e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PPARG—metabolic syndrome X	7.11e-05	9.81e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—G6PD—metabolic syndrome X	7.01e-05	9.67e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—IRS1—metabolic syndrome X	6.98e-05	9.63e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—INS—metabolic syndrome X	6.97e-05	9.62e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ALB—metabolic syndrome X	6.9e-05	9.52e-05	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—AKT1—metabolic syndrome X	6.87e-05	9.48e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	6.85e-05	9.44e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ABCA1—metabolic syndrome X	6.71e-05	9.25e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	6.71e-05	9.25e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—LPA—metabolic syndrome X	6.69e-05	9.23e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GCKR—metabolic syndrome X	6.69e-05	9.23e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—INS—metabolic syndrome X	6.69e-05	9.22e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—NOS3—metabolic syndrome X	6.6e-05	9.11e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CCL2—metabolic syndrome X	6.58e-05	9.07e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GGT1—metabolic syndrome X	6.5e-05	8.96e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GOT1—metabolic syndrome X	6.5e-05	8.96e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	6.48e-05	8.94e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—IGF1—metabolic syndrome X	6.47e-05	8.92e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—APOA5—metabolic syndrome X	6.42e-05	8.85e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ALB—metabolic syndrome X	6.39e-05	8.82e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—APOB—metabolic syndrome X	6.33e-05	8.73e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PLA2G4A—metabolic syndrome X	6.16e-05	8.49e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—SERPINE1—metabolic syndrome X	6.14e-05	8.47e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—NOS3—metabolic syndrome X	6.12e-05	8.43e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—LPL—metabolic syndrome X	6.04e-05	8.34e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PTGS2—metabolic syndrome X	6.04e-05	8.33e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—IL6—metabolic syndrome X	6.03e-05	8.32e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	5.96e-05	8.23e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—NOS3—metabolic syndrome X	5.86e-05	8.09e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CD36—metabolic syndrome X	5.74e-05	7.92e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TGFB1—metabolic syndrome X	5.6e-05	7.73e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PTGS2—metabolic syndrome X	5.59e-05	7.71e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—AKT1—metabolic syndrome X	5.56e-05	7.67e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—TGFB1—metabolic syndrome X	5.54e-05	7.64e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—APOB—metabolic syndrome X	5.51e-05	7.61e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	5.36e-05	7.4e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	5.35e-05	7.38e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PPARA—metabolic syndrome X	5.34e-05	7.36e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—LIPC—metabolic syndrome X	5.32e-05	7.33e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GCK—metabolic syndrome X	5.32e-05	7.33e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—APOC3—metabolic syndrome X	5.28e-05	7.29e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—LPL—metabolic syndrome X	5.27e-05	7.26e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—AGT—metabolic syndrome X	5.17e-05	7.13e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CETP—metabolic syndrome X	5.13e-05	7.07e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—APOE—metabolic syndrome X	5.07e-05	6.99e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—APOA1—metabolic syndrome X	5.01e-05	6.91e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CD36—metabolic syndrome X	5e-05	6.9e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—IL6—metabolic syndrome X	4.94e-05	6.82e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	4.91e-05	6.77e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	4.77e-05	6.58e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PPARA—metabolic syndrome X	4.65e-05	6.41e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	4.64e-05	6.4e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GOT2—metabolic syndrome X	4.64e-05	6.4e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—AKT1—metabolic syndrome X	4.56e-05	6.29e-05	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—AKT1—metabolic syndrome X	4.52e-05	6.23e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL6—metabolic syndrome X	4.52e-05	6.23e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—AGT—metabolic syndrome X	4.5e-05	6.21e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—APOE—metabolic syndrome X	4.41e-05	6.09e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PPARG—metabolic syndrome X	4.41e-05	6.09e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—APOA1—metabolic syndrome X	4.36e-05	6.02e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—INS—metabolic syndrome X	4.33e-05	5.97e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—IL6—metabolic syndrome X	4.22e-05	5.82e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—IL6—metabolic syndrome X	4.17e-05	5.75e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—AKT1—metabolic syndrome X	4.17e-05	5.75e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	4.13e-05	5.7e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	4.13e-05	5.7e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GGT1—metabolic syndrome X	4e-05	5.52e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GOT1—metabolic syndrome X	4e-05	5.52e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ALB—metabolic syndrome X	3.97e-05	5.47e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—AKT1—metabolic syndrome X	3.9e-05	5.37e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TGFB1—metabolic syndrome X	3.88e-05	5.35e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—AKT1—metabolic syndrome X	3.85e-05	5.31e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PPARG—metabolic syndrome X	3.84e-05	5.3e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—NOS3—metabolic syndrome X	3.8e-05	5.23e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—INS—metabolic syndrome X	3.77e-05	5.2e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PTGS2—metabolic syndrome X	3.47e-05	4.79e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ALB—metabolic syndrome X	3.46e-05	4.77e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—APOB—metabolic syndrome X	3.4e-05	4.69e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—NOS3—metabolic syndrome X	3.31e-05	4.56e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	3.3e-05	4.56e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—LPL—metabolic syndrome X	3.24e-05	4.47e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CD36—metabolic syndrome X	3.08e-05	4.25e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—AKT1—metabolic syndrome X	3.04e-05	4.19e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PTGS2—metabolic syndrome X	3.02e-05	4.17e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—IL6—metabolic syndrome X	2.92e-05	4.03e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PPARA—metabolic syndrome X	2.87e-05	3.95e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—AKT1—metabolic syndrome X	2.81e-05	3.88e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—AGT—metabolic syndrome X	2.78e-05	3.83e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—APOE—metabolic syndrome X	2.72e-05	3.75e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—AKT1—metabolic syndrome X	2.69e-05	3.72e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—APOA1—metabolic syndrome X	2.69e-05	3.71e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PPARG—metabolic syndrome X	2.37e-05	3.27e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—INS—metabolic syndrome X	2.32e-05	3.2e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ALB—metabolic syndrome X	2.13e-05	2.94e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—NOS3—metabolic syndrome X	2.04e-05	2.81e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	1.86e-05	2.57e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—AKT1—metabolic syndrome X	1.74e-05	2.41e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—AKT1—metabolic syndrome X	1.52e-05	2.1e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—AKT1—metabolic syndrome X	9.36e-06	1.29e-05	CbGpPWpGaD
